Kaposiform Hemangioendothelioma
Showing 1 - 15 of 15
Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Trial in Chengdu (Tacrolimus ointment)
Recruiting
- Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
- Tacrolimus ointment
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Jan 15, 2023
Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))
Completed
- Hemangioma
- Kaposiform Hemangioendothelioma
-
Shanghai, ChinaChildren's Hospital of Fudan University
Jan 27, 2023
Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
- Kasabach-Merritt Syndrome
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Oct 21, 2022
Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)
Recruiting
- Kaposiform Hemangioendothelioma
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Apr 6, 2022
Sirolimus on Immunizations During Treatment of Kaposiform
Recruiting
- Kaposiform Hemangioendothelioma
-
Shanghai, Shanghai, ChinaChildren's Hospital of Fudan University
Apr 22, 2022
Hemangioendothelioma Trial in Chengdu (Sirolimus)
Recruiting
- Hemangioendothelioma
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
May 1, 2022
Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies Trial in Shanghai (Percutaneous sirolimus, Oral
Recruiting
- Kaposiform Hemangioendothelioma
- +3 more
- Percutaneous sirolimus
- Oral sirolimus
-
Shanghai, ChinaChildren's Hospital of Fudan University
Jan 9, 2023
Lymphatic Malformation, Generalized Lymphatic Anomaly (GLA), Central Conducting Lymphatic Anomaly Trial in Boston
Recruiting
- Lymphatic Malformation
- +9 more
-
Boston, MassachusettsBoston Children's Hospital
Sep 8, 2022
Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted Angioma Trial in United States (Vincristine, Sirolimus)
Terminated
- Kaposiform Hemangioendothelioma (KHE)
- +2 more
-
Palo Alto, California
- +6 more
May 20, 2021
Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP) Trial in Shanghai (prednison and Sirolimus,
Not yet recruiting
- Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
- prednison and Sirolimus
- prednison
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center Shanghai Jiaotong University
Jun 5, 2020
Vascular Anomalies Trial in Guangzhou (Treatment with oral rapmycin)
Recruiting
- Vascular Anomalies
- Treatment with oral rapmycin
-
Guangzhou, Guangdong, ChinaZhujiang Hospital
Nov 9, 2021
Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)
Recruiting
- Angiosarcoma
- Epithelioid Hemangioendothelioma
-
Boston, Massachusetts
- +1 more
Feb 14, 2022
PIVKA-II Combined With Alpha-Fetoprotein for Diagnostic and
Completed
- Hepatoblastoma
- Hepatic Hemangioendothelioma
- PIVKA-II
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center, Shanghai Jiaotong University
Jul 16, 2021
Hemangioendothelioma of Liver Trial in Shanghai (Sirolimus Oral Product, propranolol)
Not yet recruiting
- Hemangioendothelioma of Liver
- Sirolimus Oral Product
- propranolol
-
Shanghai, Shanghai, ChinaShanghai Children's Medical Center Shanghai Jiaotong University
May 23, 2020
Kaposiform Hemangioendotheliomas, Tufted Angioma, Capillary Venous Lymphatic Malformation Trial in Boston, Cincinnati
Unknown status
- Kaposiform Hemangioendotheliomas
- +8 more
-
Boston, Massachusetts
- +1 more
Feb 3, 2015